Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer

Clinical Cancer Research

Volumn 11, Issue 11, 2005, Pages 4117-4127

  Murphy, Catherine ^a   McGurk, Maryalice ^a   Pettigrew, Johanna ^a   Santinelli, Alfredo ^b   Mazzucchelli, Roberta ^b   Johnston, Patrick G ^a   Montironi, Rodolfo ^b   Waugh, David J J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 8; KI 67 ANTIGEN;

ADVANCED CANCER; AGED; APICAL MEMBRANE; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DENSITY; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROVASCULATURE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

AGED; ANDROGENS; BIOPSY; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYTOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; TUMOR MARKERS, BIOLOGICAL;

EID: 20344392179     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1518     Document Type: Article

References (24)

1. Inoue K, Slaton JW, Eve BY, et al. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 2000;6:2104-19.
2. Kim SJ, Uehara H, Karashima T, McCarty M, Shih N, Fidler IJ. Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia 2001;3:33-42.
3. Heiland J, Furcht LT, McCarthy JB. CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate 1999;41:78-88.
4. Veltri RW, Miller MC, Partin AW, Poole EC, O'Dowd GJ. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Cancer 1999;91:2322-8.
5. McCarron SL, Edwards S, Evans PR, et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 2002;62:3369-72.
6. Lee LF, Louie MC, Desai SJ, et al. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK. Oncogene 2004;23:2197-205.
7. Anderson J, Reddy VB, Green L, et al. Role of expression of cell cycle inhibitor p27 and MIB-1 in predicting lymph node metastasis in male breast carcinoma. Breast J 2002 Mar-Apr;8:101 -7.
8. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
9. Ferrer FA, Miller LJ, Andrawis RI, et al. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 1998;51:161-7.
10. Moore BB, Arenberg DA, Stoy K, et al. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol 1999;154:1503-12.
11. Aaltomaa S, Eskelinen M, Lipponen P. Expression of cyclin A and D1 proteins in prostate cancer and their relation to clinopathological variables and patient survival. Prostate 1999;38:175-82.
12. Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res 2001;6:1891-5.
13. Barlic J, Khandaker MH, Mahon E, et al. β-Arrestins regulate interleukin-8-induced CXCR1 internalization. J Biol Chem 1999;274:16287-94.
14. Prado GN, Suzuki H, Wilkinson N, Cousins B, Navarro J. Role of the C-terminus of the interleukin-8 receptor in signal transduction and internalization. J Biol Chem 1996;271:19186-90.
15. Ludwig A, Ehlert JE, Flad H-D, Brandt E. Identification of distinct surface-expressed and intracellular CXC-chemokine receptor 2 glycoforms in neutrophils: N-glycosylation is essential for maintenance of receptor surface expression. J Immunol 2000;165:1044-52.
16. Takamori H, Oades ZG, Hoch OC, Burger M, Schraufstatter IU. Autocrine growth effect of IL-8 and GROα on a human pancreatic cancer cell line, Capan-1. Pancreas 2000;21:52-6.
17. Venkatakrishnan G, Salgia R, Groopman JE. Chemokine receptors CXCR1/2 activate mitogen activated protein kinasevia theepidermal growth factor in ovarian cancer cells. J Biol Chem 2000;275:6868-75.
18. Xu L, Fidler IJ. Interleukin 8: an autocrine growth factor for human ovarian cancer. Oncol Res 2000;12:97-106.
19. Li A, Varney ML, Singh RK. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 2001;7:3298-304.
20. Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 2000;12:78-85.
21. Uzgare AR, Kaplan PJ, Greenberg NM. Differential expression and/or activation of p38 MAPK, Erk1/2 and Jnk during the initiation and progression of prostate cancer. Prostate 2003;55:128-39.
22. Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003;170:3369-76.
23. Varney ML, Olsen KJ, Mosley RL, Bucana CD, Talmadge JE, Singh RK Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis. In Vivo 2002l;16:471-7.
24. Li A, Dubey S, Varney ML, Singh RK. Interleukin-8-induced proliferation, survival, and MMP production in CXCR1 and CXCR2 expressing human umbilical vein endothelial cells. Microvasc Res 2002;64:476-81.